Itch is the hallmark symptom of atopic dermatitis and the major source of patient suffering. In caring for these patients, it is important to understand the underlying mechanism and the manner in which treatments target these mechanisms to reduce pruritus. This lecture will formulate an approach for the treatment of different types of AD itch and describe upcoming drugs in clinical targeting of itch and AD.
This activity has been designed to meet the educational needs of clinicians and non-clinicians involved in the care of patients with atopic dermatitis.
- Formulate an approach for the treatment of different types of AD itch
- Describe upcoming drugs in clinical targeting of itch and AD
Disclosure of Conflicts of Interest
Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational programs. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing its learners with high-quality activities that promote improvements or quality in health care and not the business interest of a commercial interest.
The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:
|Name of Faculty||Reported Financial Relationship|
|Gil Yosipovitch, MD||
Grants/Research Support: Leo, Kiniksa, Pfizer, Sun Pharma, Vanda, Regeneron
Consulting Fees (e.g. Advisory Board): Menlo, Trevi, Sienna, Galderma, Regeneron Sanofi, Novartis, Eli Lilly, Pfizer, Kiniksa, AbbVie, Bayer, Ortho, Bellus, Cerave,
The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:
|Name of Content Manager||Reported Financial Relationship|
|Venita Sivamani, Planner||LearnHealth founder and shareholder|
|Planners at Medical Education Resources||No financial relationships to disclose|
|In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and LearnHealth. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.|
Medical Education Resources designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Medical Education Resources designates this live activity for a maximum of 0.5 ANCC nursing contact hours. Nurses will be awarded contact hours upon successful completion of the activity.
Method of Participation
There are no fees for participating in and receiving credit for this activity. During the period August 31, 2021 through July 14, 2022, participants must 1) read the learning objectives and faculty disclosures, 2) study the educational activity, 3) complete the posttest by recording the best answer to each question, and 4) complete the evaluation form.
A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed posttest with a score of 70% or better. Statements of credit will be issued.
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, LearnHealth, and/or Pfizer. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
Medical Education Resources and LearnHealth maintain high standards for the protection of privacy over the Internet. The purpose of this statement is to explain what information we obtain, how it is used, and how visitors can restrict its use or disclosure.
The only information MER obtains is information supplied voluntarily by the visitor.
We do not sell or disclose individually identifiable information obtained online unless it is required by law or disclosure is necessary to protect the safety of customers, employees, or property.
We use the information to grade your posttest and to send you a certificate of completion of the activity. If we use a third-party company to grade your posttest and issue certificates of completion, we will give the information to that company for that purpose only.
For each activity that you take, you must complete an evaluation questionnaire. That questionnaire asks if you are willing to participate in a follow-up survey. If you answer yes, we will use your name and contact information to send you the survey.
We may use the information to invite you to participate in other activities that we may offer.